TMS Insurance Coverage in California: Preparing for Approval

TMS Insurance Coverage in California: Preparing for Approval

Transcranial magnetic stimulation (TMS) is a non-invasive treatment most often considered for adults with major depressive disorder when standard treatments have not provided enough relief. It uses magnetic pulses delivered to targeted areas of the scalp and does not require surgery or anaesthesia.

In the United States, TMS was cleared by the FDA for major depressive disorder in 2008, and for depression with comorbid anxiety in 2021. However, FDA clearance does not mean that every health plan will automatically cover treatment. Most insurers require prior authorisation and supporting clinical records before approving a course of TMS.

For people in California, preparing those records early can reduce delays and help the treating clinician or TMS clinic submit a clearer request.

Why insurers ask for prior authorisation

Prior authorisation is a review process used by an insurer before it agrees to cover a treatment. The insurer reviews whether the requested care meets the medical-necessity rules in the member’s specific plan.

For TMS, the review commonly focuses on:

• The diagnosis being treated
• Current symptoms and their severity
• Previous antidepressant medication trials
• Previous or current talking therapy
• Whether depression has continued despite appropriate treatment
• Whether TMS is clinically appropriate and safe
• Whether there are reasons TMS should not go ahead

Requirements differ between plans, even where people have the same insurance company. A Blue Shield of California policy, for example, may have different rules depending on whether cover is obtained through an employer, the individual market, Medicare arrangements or another programme. The same principle applies to Anthem Blue Cross of California, Kaiser Permanente, UnitedHealthcare, Aetna, Cigna, Health Net and other carriers.

Medi-Cal managed care plans, Medicare administered in California through Noridian Jurisdiction E, and TRICARE West may also have their own coverage rules and documentation processes.

The clinic should check the patient’s individual benefits rather than relying only on the insurer’s general name.

The clinical evidence insurers commonly request

TMS is usually considered after depression has not improved sufficiently with other evidence-based treatments. Insurers commonly want documentation showing that these treatments were tried, tolerated where possible, and reviewed by a prescribing clinician.

Medication history

A prior-authorisation request often includes a detailed list of antidepressant medication trials. Insurers may look for evidence that medications were prescribed at an appropriate dose and for a suitable period, unless they were stopped earlier because of side effects, safety concerns or another clinical reason.

Useful medication records may include:

• The medication name
• The dose or dose range prescribed
• Approximate start and stop dates
• Why it was discontinued or changed
• Whether it was ineffective, only partly effective, or poorly tolerated
• Noted side effects
• Records of augmentation or combination treatment, where relevant

It is important not to assume that a medication trial is missing simply because a person cannot remember every detail. Old prescribing notes, pharmacy histories and records from a GP, psychiatrist or previous mental-health provider may help fill gaps.

A person should be honest about medication use. If a medicine was not taken consistently, it is better for the treating clinician to understand why. There may have been side effects, cost barriers, pregnancy planning, concerns about interactions, difficulty collecting prescriptions or other legitimate issues that belong in the clinical record.

Therapy history

Many insurers also ask for evidence of psychotherapy or counselling, particularly structured treatment for depression. This does not necessarily mean that every person needs the same form or length of therapy. The requirement depends on the plan and the individual’s clinical circumstances.

Relevant information may include:

• The type of therapy, if known
• The provider’s name and professional role
• Approximate treatment dates
• How often sessions took place
• Whether symptoms improved, stayed much the same or worsened
• Reasons therapy was not available, not tolerated or not suitable

If therapy was received through a community provider, employee assistance programme, telehealth service, school or university setting, or a previous health plan, records may need to be requested separately. A brief letter or treatment summary from the therapist can sometimes be useful if full notes are not needed or cannot be shared.

Symptom scores and clinical assessments

Depression severity is often tracked with validated questionnaires. Insurers may ask for recent symptom scores and may require continued measurement during treatment. These tools do not replace a clinical assessment, but they give a consistent way to document symptoms and change over time.

The treating clinician may record information about low mood, loss of interest, sleep, appetite, concentration, energy, guilt, psychomotor changes and thoughts of self-harm. They will also consider how symptoms affect work, study, relationships, caring responsibilities and daily routines.

Bring any recent psychiatric evaluation or depression screening records to the consultation. If no formal scores have been completed previously, the evaluating clinician may administer an appropriate measure as part of the TMS assessment.

How the prior-authorisation process usually works

The process commonly begins with a TMS evaluation. A psychiatrist or other qualified clinician assesses the diagnosis, treatment history, current symptoms and suitability for TMS. They may also review medical issues that could affect treatment planning, including implants, metal near the head, seizure history and medications.

After the evaluation, the clinic’s authorisation team may verify benefits and request records. The clinic then sends the insurer a prior-authorisation submission, which may include the clinician’s assessment, treatment history, symptom measures and a proposed treatment plan.

A standard TMS course is commonly delivered on weekdays over roughly six to nine weeks, with about 36 sessions. Coverage policies may specify how treatment sessions are authorised, how progress is reviewed and when additional approval is needed.

The insurer may then:

• Approve the requested course
• Ask for more information
• Approve only part of the proposed treatment initially
• Deny the request because its criteria are not yet documented as met

An approval is not always a statement that all costs will be paid in full. Deductibles, co-payments, co-insurance, out-of-network rules and annual benefit arrangements can still affect the amount a patient pays. Ask the clinic and insurer for a benefits estimate, but remember that an estimate is not a guarantee of payment.

Gathering records before your consultation

Starting early is often the most practical step. Create a simple timeline of depression treatment, even if some dates are approximate. Include medications, therapy, hospital or urgent-care visits where relevant, changes in clinicians and major treatment outcomes.

You may wish to gather:

• Contact details for current and former prescribers
• Psychiatric evaluations and progress notes
• Medication lists and pharmacy dispensing histories
• Therapy summaries or attendance records
• Recent depression questionnaire results
• Relevant medical records, including previous neurology or seizure-related assessments where applicable
• Your insurance card and plan information
• Any prior authorisation or denial letters you have already received

Ask providers what their process is for releasing records and allow time for this. Some records departments require a signed release form. Keep copies of what you send or receive, along with dates, names of people spoken to and reference numbers from the insurer.

If records are incomplete, do not delay seeking an evaluation. A TMS clinic may be able to identify what is missing and help request the most relevant documents.

If an insurer asks for more information or denies cover

A request for more information is common and does not necessarily mean that TMS has been ruled out. The clinic may need to clarify medication doses, explain why a medication ended early, provide therapy documentation or submit updated symptom assessments.

If cover is denied, read the denial notice carefully. It should state the reason and explain any appeal rights. A denial may relate to missing information rather than a disagreement about the need for treatment.

Possible next steps include:

• Asking the clinic to review the denial reason
• Checking whether records were omitted or unclear
• Requesting a clinician letter explaining the treatment history
• Asking about the insurer’s internal appeal process
• Confirming deadlines for any appeal
• Speaking directly with the insurer using the number on the insurance card

Keep communication factual and organised. A clear treatment timeline and complete records can be particularly helpful during reconsideration or appeal.

Finding TMS support in California

TMS Therapy California lists 382 published clinics across the state. Directory listings include clinics in Los Angeles, San Diego, Carlsbad, Sacramento, San Jose, Long Beach, Aliso Viejo, Chula Vista, Simi Valley, Roseville, Irvine and Davis, among other California locations.

When contacting a clinic, ask whether it works with your insurer, whether it submits prior authorisation requests, and what records it needs before the assessment. Clinics cannot promise approval, but an experienced administrative team may help explain the steps and identify missing documentation.

Getting help in California

Use the TMS Therapy California clinic listings to find local providers, read the directory’s insurance guide for practical coverage information, or visit the contact page for further assistance.

This article is educational information, not medical advice.